한국어
English
日本語
中文(简体)
Makyusell Tablet 0.5 mg (Trametinib Dimethyl Sulfoxide)
0.5635mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.
Trametinib dimethyl sulfoxide is an anticancer agent that inhibits the growth of malignant tumors.
MFDS ingredient code M282096
Trametinib dimethyl sulfoxide is an anticancer agent that selectively inhibits the MEK enzyme and is primarily used to prevent the proliferation of specific cancer cells. This component is classified as a molecular targeted therapy that plays a role in blocking cancer cell signaling pathways.
Trametinib dimethyl sulfoxide inhibits the activity of the MEK enzyme within cancer cells, thereby blocking the signals for cancer cells to grow and divide. As a result, there is a reduction in cancer cell proliferation and a decrease in tumor size.
Approved uses differ by product. Check each product's information for its actual use.
Trametinib dimethyl sulfoxide is characterized as an undifferentiated form of MEK inhibitor that improves the absorption and bioavailability of the drug. Unlike other anticancer agents, it targets specific signaling pathways to reduce side effects and enhance efficacy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
